NOVEL CELL-PERMEABLE SUCCINATE COMPOUNDS

The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which...

Full description

Saved in:
Bibliographic Details
Main Authors EHINGER, KARL HENRIK JOHANNES, ELMÉR, ESKIL, HANSSON, MAGNUS JOAKIM, MOSS, STEVEN
Format Patent
LanguageEnglish
Polish
Published 31.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.
AbstractList The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria. The main part of ATP produced and utilized in the eukaryotic cell originates from mitochondrial oxidative phosphorylation, a process to which high-energy electrons are provided by the Kreb's cycle. Not all Kreb's cycle intermediates are readily permeable to the cellular membrane, one of them being succinate. The provision of the novel cell permeable succinates is envisaged to allow passage over the cellular membrane and thus the cell permeable succinates can be used to enhance mitochondrial ATP-output.
Author EHINGER, KARL HENRIK JOHANNES
ELMÉR, ESKIL
HANSSON, MAGNUS JOAKIM
MOSS, STEVEN
Author_xml – fullname: EHINGER, KARL HENRIK JOHANNES
– fullname: ELMÉR, ESKIL
– fullname: HANSSON, MAGNUS JOAKIM
– fullname: MOSS, STEVEN
BookMark eNrjYmDJy89L5WTQ8PMPc_VRcHb18dENcA3ydXV08nFVCA51dvb0cwxxVXD29w3wD_VzCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEBPsaGRpYGhmYhIcbGxKgBAAA1Jlg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate NOWE PRZEPUSZCZALNE DLA KOMÓREK ZWIĄZKI BURSZTYNIANU
ExternalDocumentID PL3129016TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_PL3129016TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:46 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL3129016TT33
Notes Application Number: PL20150714820T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181031&DB=EPODOC&CC=PL&NR=3129016T3
ParticipantIDs epo_espacenet_PL3129016TT3
PublicationCentury 2000
PublicationDate 20181031
PublicationDateYYYYMMDD 2018-10-31
PublicationDate_xml – month: 10
  year: 2018
  text: 20181031
  day: 31
PublicationDecade 2010
PublicationYear 2018
RelatedCompanies Neurovive Pharmaceutical AB
RelatedCompanies_xml – name: Neurovive Pharmaceutical AB
Score 3.1794431
Snippet The present invention provides novel cell-permeable succinates and cell permeable precursors of succinate aimed at increasing ATP-production in mitochondria....
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NOVEL CELL-PERMEABLE SUCCINATE COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20181031&DB=EPODOC&locale=&CC=PL&NR=3129016T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNpzLnBxWk-FJcm65dH4qsacqU9IOtHXsbS5vCQLS4iv--aW3VF30LCVySI3eXu9z9AnBrVqkV5nqt5FqGFF3XhR5k40xROecjcz1k4xqBzw-MaaI_LUfLDmzaWpgaJ_SjBkcUEpUKeS9rfV38BLHcOrdye882ouv1wYttV268Y2GuxCGVXccmUeiGWMbYjqgczGxUxVtUI0Y7sFvdoiuYfbJwqqKU4rdF8Y5gLxLEXspj6BTPPTjA7cdrPdj3m_du0WxEb3sCd0G4IFTChFIlIjOfTBxKpHmC8WMwiYmEQz8Kk8Cdn8KNR2I8VcSUq-_trSLaLi5G6Ay6wu3nfZBUbqWWppkM5UM91w1mCMueaWmWMstiGjqHwd90Bv8NXsBhxaovDXwJ3fLtnV8J01qy65opn30jeVQ
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTmXOrwpSfCmuTdeuD0W2NGPT9IOtG3sbTZvBQHS4iv--17qpL_oWEsjHkbsfd7n7BeDWLlIr7CTRFkZGNNM00Q6KTqbpUsq2nbREp2Tg8wNrMDEfZ-1ZBZbbWpiSJ_SjJEdEjUpR3_PSXq9-glhemVu5vhdL7Hp96Meup268Y4QrvKSq13NZFHohVSl1I64GI5cU8RbdiskO7NroERY0-2zaK4pSVr8RpX8IexFO9pIfQWX1XIca3X68Vod9f_Pejc2N6q2P4S4Ip4wrlHGuRWzks26PM2U8oXQYdGOm0NCPwkngjU_gps9iOtBwyfn38eYR324uJuQUquj2ywYounRSxzBsQRYtc2FawkJkz4w0S4XjCIOcQfPveZr_DV5DbRD7fM6HwdM5HBRi-7LGF1DN397lJcJsLq5KAX0CT3F8Pw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NOVEL+CELL-PERMEABLE+SUCCINATE+COMPOUNDS&rft.inventor=EHINGER%2C+KARL+HENRIK+JOHANNES&rft.inventor=ELM%C3%89R%2C+ESKIL&rft.inventor=HANSSON%2C+MAGNUS+JOAKIM&rft.inventor=MOSS%2C+STEVEN&rft.date=2018-10-31&rft.externalDBID=T3&rft.externalDocID=PL3129016TT3